Keywords: neurocrine, discontinues, msp771, dosing, biosciences, been, advised

Neurocrine discontinues MSP771 dosing

Article | 22 July 1999

Print This

Neurocrine Biosciences has been advised by the US Data and SafetyMonitoring Board to cease dosing of MSP771 in a Phase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in